AI Article Synopsis
- DIHS/DRESS is a severe drug reaction characterized by multi-organ involvement and herpesvirus reactivation, usually following prolonged drug exposure.
- It presents in waves of exacerbation and remission, with potential severe and fatal complications linked to virus reactivation.
- The disease involves complex immune interactions, particularly between various T cells, but the exact mechanisms and reasons for autoimmune complications remain unclear, warranting further study.
Article Abstract
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS) is a severe type of adverse drug eruption associated with multiorgan involvement and the reactivation of human herpesvirus 6, which arises after prolonged exposure to certain drugs. Typically, two waves of disease activity occur during the course of DIHS/DRESS; however, some patients experience multiple waves of exacerbation and remission of the disease. Severe complications, some of which are related to cytomegalovirus reactivation, can be fatal. DIHS/DRESS is distinct from other drug reactions, as it involves herpes virus reactivation and can lead to the subsequent development of autoimmune diseases. The association between herpesviruses and DIHS/DRESS is now well established, and DIHS/DRESS is considered to arise as a result of complex interactions between several herpesviruses and comprehensive immune responses, including drug-specific immune responses and antiviral immune responses, each of which may be mediated by distinct types of immune cells. It appears that both CD4 and CD8 T cells are involved in the pathogenesis of DIHS/DRESS but play distinct roles. CD4 T cells mainly initiate drug allergies in response to drug antigens, and then herpesvirus-specific CD8 T cells that target virus-infected cells emerge, resulting in tissue damage. Regulatory T-cell dynamics are also suggested to contribute to the diverse symptoms of DIHS/DRESS. However, the pathomechanisms of this complex disease remain largely unknown. In particular, how viral infections contribute to the pathogenesis of DIHS/DRESS and why autoimmune sequelae arise in DIHS/DRESS are yet to be elucidated. This review describes the clinical features of DIHS/DRESS, including the associated complications and sequelae, and discusses recent advances in our understanding of the immunopathogenic mechanisms of DIHS/DRESS.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927043 | PMC |
| http://dx.doi.org/10.3390/ijms22042147 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
CMV complications in DIHS/DRESS: Importance of routine monitoring and early therapeutic intervention.
Clin Exp Dermatol
September 2024
Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
The fatal outcomes in DIHS/DRESS are reported to be associated with CMV reactivation. However, CMV reactivation is also observed not only in DIHS/DRESS but also in other diseases when high doses of corticosteroids are administered. Currently, it is difficult to distinguish whether CMV reactivation in DIHS/DRESS is caused by steroid-induced immunosuppression or the pathology of DIHS/DRESS.
View Article and Find Full Text PDFFrom Viral Infection to Autoimmune Reaction: Exploring the Link between Human Herpesvirus 6 and Autoimmune Diseases.
Microorganisms
February 2024
Institute of Microbiology and Virology, Riga Stradins University, LV-1067 Riga, Latvia.
The complexity of autoimmunity initiation has been the subject of many studies. Both genetic and environmental factors are essential in autoimmunity development. Among others, environmental factors include infectious agents.
View Article and Find Full Text PDFA case of drug-induced hypersensitivity syndrome complicated with fulminant type 1 diabetes and type 2 myocardial infarction.
J Dermatol
December 2023
Department of Dermatology, Tachikawa Hospital, Federation of National Public Service Personnel Mutual Aid Associations, Tokyo, Japan.
Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) is a type of drug eruption that causes multiorgan disorders after the administration of certain drugs such as anticonvulsants. Herein, we report the case of a 66-year-old man with DiHS/DRESS complicated by fulminant type 1 diabetes (FT1D), shock, and cardiac involvement who was treated conservatively without systemic corticosteroid administration. He had taken carbamazepine for trigeminal neuralgia for 7 weeks until he noticed eruptions on his trunk.
View Article and Find Full Text PDFDrug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis.
J Am Acad Dermatol
May 2024
Department of Dermatology, Yale School of Medicine, New Haven, Connecticut. Electronic address:
Article Synopsis
- Drug-induced hypersensitivity syndrome (DiHS), also known as DRESS, is a serious skin reaction that includes symptoms like fever and involvement of internal organs, commonly triggered by medications like anticonvulsants and antibiotics.
- The condition typically arises 2-6 weeks after drug exposure and is driven by a complex interaction between the drugs, viruses, and the immune system, particularly T-cells.
- This continuing medical education activity aims to inform healthcare professionals about the latest trends in DiHS/DRESS's epidemiology, underlying mechanisms, and clinical features for better prognosis and treatment.
Drug-Induced Hypersensitivity Syndrome/Drug Reaction With Eosinophilia and Systemic Symptoms: Predictive Score and Outcomes.
J Allergy Clin Immunol Pract
October 2023
Department of Dermatology, Kyorin University School of Medicine, Mitaka, Tokyo, Japan.
Article Synopsis
- A study developed a Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) severity (DDS) score to predict complications associated with drug-induced hypersensitivity syndrome (DIHS), particularly looking at severe complications like myocarditis and autoimmune diseases.
- A retrospective analysis of 48 patients in Japan identified that a higher DDS score (≥4.0) could indicate a higher risk for these complications, while no complications were seen in those with lower scores (≤2.0).
- Findings suggested that the use of corticosteroids may increase the risk of certain complications and deaths, particularly in patients with infectious diseases, while early treatment for cytomegalovirus seemed to prevent complications.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!